Search details
1.
Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.
Invest New Drugs
; 39(3): 812-820, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33409898
2.
Fluorescence techniques used to measure interactions between hydroxyapatite nanoparticles and epidermal growth factor receptors.
Biotechnol J
; 10(1): 171-9, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25367700
3.
The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles.
Biomaterials
; 32(32): 8218-25, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21807406
Results
1 -
3
de 3
1
Next >
>>